- Discussion:
-
NSAIA;
- Rheumatoid and Osteoarthritis, Ankylosing spondylitis;
- Dosage: 10-20mg PO qd (has an extended half life);
- therapeutic response should only be assessed after two weeks or more of continuous treatment;
- may cause diarrhea;
- Contraindicated in patients with syndrome of bronchospasm, nasal polyps,
angioedema precipitated by ASA or other
NSAIA;
- Use with caution in patients
with a h/o upper GI bleeding, heart failure,
renal insufficiency, liver dysfunction, hypertension and in patients
with other conditions predisposing to fluid retention;
The effect of piroxicam on the metabolism of isolated human chondrocytes.
